Clinical Trial Update: Study to Evaluate Safety and Efficacy of Dutogliptin in Type 2 Diabetes Mellitus Subjects With Moderate and Severe Renal Impairment [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of dutogliptin in adults with Type 2 Diabetes Mellitus and moderate to severe renal impairment has been termina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Dutogliptin (dutogliptin)

Snippet

Sponsor: Phenomix | Conditions: Type 2 Diabetes Mellitus, Renal Impairment | Phase 3 | Status: TERMINATED